Temple University School of Medicine - Skull Yearbook (Philadelphia, PA)

Page 20 text:

The Temple University Medical Center has grown from humble beginnings since its inception in 1901, into a vast institution which has served and is serving both the community and the medical profession. Close to 5000 physicians have been graduated and hundreds of post-graduates have, been trained as interns and residents. Countless patients have received care, both as in-patients and in the clincs. In 1962 alone more than 25,000 patients were admitted to the hospital and in excess of 200,000 visits were made to the clinics. This institution, being a center of medical education, has another role which it must fulfill and that is in the field of basic medical research. Basic research in the health sciences is at the very heart of medical progress. It not only strengthens the foundations of basic medical knowledge, but it broadens and enriches those who participate in it. The teacher who participates in research is better equipped to create an environment which will inspire the student and stimulate his curiosity. The student, whether he becomes a researcher or a clinician, will benefit from any exposure he has had to basic research. After such exposure he will not accept all data as factual without question. Temple has risen to meet this challenge. In the last decade, research at Temple has grown by over 1000 per cent. The facts speak for themselves. The money available for research in the year 1951-52 was around $250,000, while in the year 1961-62, the money available for research approached $3,500,000. Although research at Temple had grown at an astounding rate, the space available for research had remained almost the same. Three years ago it became obvious that if research was to continue expanding at its present rate, more physical space for research and research alone would be required. In 1961, a grant from the U.S. Public Health Service and the Samuel S. Pels Fund made it possible for construction to begin on a modern basic science research building. This building will have space available for the research efforts of all the basic medical sciences. It’s opening in the spring of 1963 marked another milestone in the efforts of Temple to meet the challenge of the future. Groundbreaking ceremonies (Feb. 8, 1961) for Temple University’s Medical Research Building. Foreground: left: Dr. Millard E. Gladfelter, President of Temple University, right: Judge Charles Klein, Chairman of Temple University Board of Trustees. Background (left to right): Russell Conwcll Cooney, Esq., Board of Trustees; Dr. Robert L. Johnson, Chancellor; (partially shown) Mr. Lewis Stevens, President of the Samuel S. Fels Fund; Dr. Richard A. Kern. Chainnan of the Medical School-Hospital Committee; and Dr. Robert M. Bucher, Dean of the School of Medicine. Medical Reset ch Buildins 16

Page 19 text:

the aorta, vena cavae and other peripheral vessels. Electrokymography, designed at Temple in 1945 by Drs. Chamberlain, Boone, and Henry, has been used extensively in Europe in studying cardiac border movements and silhouette densities. It is based on recording changes in movement and density of the heart onto a fluoroscopic screen and converting the picture into electrical patterns. These are only a few of the projects on which Dr. Stauffer's group has been engaged. They serve to reemphasize the leading role Temple has played in the field-of radiologic research and its clinical application. Stereotaxic Surgery For the past fifteen years, Drs. Wycis and Spiegel have been working with new surgical methods in an effort to devise surgical treatment for diseases of the brain. Perhaps the best known contribution of this distinguished Temple team has been the application of stereotaxic surgery to such disorders as Parkinsonism. In the late nineteen thirties and early nineteen forties surgeons around the world, in particular a Dr. Mayers at Iowa, stumbled onto the area of the brain responsible for the shaking and tremor seen in Parkinsonism and other such disorders — the area of basal ganglia Now it remained for surgeons to find a way to hit that target area in the brain without unduly harming other areas. The first step was taken by the team at Temple University Medical Center, headed by world famous neurophysiologist, Dr. Ernest Spiegel, and one of his brilliant American students, Dr. Henry Wycis. Together they developed a special machine for aiming electrodes into localized areas of the brain. This device is called a stcreoencephalotome. Then the two men devised a new kind of brain map enabling doctors, by mathematical calculations, to find the exact location of any brain center. Through the use of the stereoencephaloiome and the brain atlas Drs. Spiegel and Wycis have been able to pass electrodes into the basal ganglia and destroy parts of such brain centers. Today the two men continue to work exploring new centers in the brain, looking for new and better methods of application of the stcreoencephalotome. Such disorders as cerebral palsy and epilepsy also may be helped by the continued work of these two great pioneers. Pels Institute The Samuel S. Fcls Research Institute has its inception in 1933 and Dr. Harry Shay has been its Director since then. The major areas of research being investigated are gastroenterology, both basic physiology and clinical research, and cancer research. The complete personnel of the Institute now numbers sixty-two, including seven physicians, four Ph.Ds, three with Masters, along with many technicians at the Bachelor adadcmic level. The facilities are curently housed in the Medical School and at Barton Hall Until the new research building is available for occupancy, the latter houses the laboratories of Dr. Sidney Weinhouse. who joined the Institute in January 1962, as Associate Director of the Institute as well as Professor of Biochemistry in the Medical School. ’lTte Institute will also occupy the seventh and eighth floors in the new- research building, thus, greatly enlarging its present facilities. This will permit an increase of our research staff. Several additional senior investigators are contemplated and one very important investigator, Dr. Michael Shimkin, will be joining both the Medical School and the Institute in July. Dr. Shimkin is now Associate Director for field studies of the National Cancer Institute and Scientific Editor of the Journal of the National Cancer Institute. He is also Chairman of the Ad Hoc Research Advisory Committee on Breast Cancer for the American Cancer Society. Dr. Shimkin will be Professor of Medicine in the Medical School and Chief of Cancer Biology in the Institute. The expanding Institute currently has budget of over $500,000. In gastroenterology the research areas have included basic physiology, gastric secretion and motility, pancreatic function with the development of an adequate pancreatic function profile. In the liver area, jaundice and sensitization of the liver to drugs have been the major areas of investigation. The Fcls Research Institute has been in a large measure responsible for the development of the rat as an experimental tool in gastric secretion. One such preparation, in use very extensively for many years and referred to in the literature as the Shay rat, has been the experimental tool used by investigators in over five hundred publications. Dr. Komarov and Dr. Bralow have recently developed a chronic gastric fistula in the rat which promises to enhance even more the value of this animal in research in gastrointestinal physiology. We expect to utilize this preparation in the detailed study of the effect of the endocrine glands on gastric secretion over the next two or three years. In the cancer area the Institute has developed two major methods of investigation. One, is a method for the induction of myelogenous leukemia in the rat which is readily transferred. This preparation has been shipped to more than forty research laboratories around the world where the preparation is in use for research in leukemia. Another important tool that has been developed in the laboratory is a method for the development of breast cancer in female rats in very high incidence and the study of this tumor to show that in its hormonal relationships it very closely mimics the behavior of human breast cancer. In the past two years this system has been modified to produce reproducible breast cancer in low incidence, a system that will lend itself admirably for the study of cocarcinogcnic and promoting agents. Particularly applicable will this system be for a search for these agents in foods and food additives. Furthermore, our method for the induction of breast cancer in the rat has also made possible the development of a system for the study of cancer chemotherapeutic agents. It is for the development of this system that the Institute was awarded a contract by the Cancer Chemotherapy National Service Center some two years ago. The biochemical studies are concerned largely with the chemistry of the cancer cell and with glucose metabolism 15

Page 21 text:

Administration MILLARD E. GLADFELTEK Ph.D., D.Sc. in Ed.. LL.D.. Litt.D., L.H.D President of the University HOWARD W. BAKER. M I . Chief Administrator of Temple University Medical Center WILLIAM N. PARKINSON, M.D. M.Sc. ( Medicine), F.A.C.S., LL.D., Sc.D.. Dean Emeritus